의학 진단 시장 크기, 2025-2035에 있는 유럽 AI

---

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Europe Artificial Intelligence (AI) in Medical Diagnostics Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Streamlined workflows reduce diagnostic turnaround times significantly.

3.2.2. Favorable policies promote AI integration in healthcare systems.

3.2.3. Innovations enhance accuracy in medical diagnostics using AI.

3.3. Key industry pitfalls & challenges

3.3.1. Significant investment required for AI implementation.

3.3.2. Shortage of trained professionals in AI and healthcare.

3.3.3. Protecting patient data remains a significant challenge.

3.4. Market Opportunities

3.4.1. AI can enhance remote patient monitoring and management.

3.4.2. Opportunities for alliances between tech and healthcare firms.

3.4.3. AI can tailor diagnostics to individual patient profiles.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Europe Artificial Intelligence (AI) in Medical Diagnostics Market, Application Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Application, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Imaging Diagnostics

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Genomic Diagnostics

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Laboratory Diagnostics

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Preventive Diagnostics

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Clinical Decision Support

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Europe Artificial Intelligence (AI) in Medical Diagnostics Market, Disease Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Disease, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Oncology

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Cardiovascular Diseases

5.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.4. Neurological Disorders

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Respiratory Diseases

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Diabetes

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.7. Infectious Diseases

5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.8. Others

5.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Europe Artificial Intelligence (AI) in Medical Diagnostics Market, Region Segment Analysis

6.1. Overview

6.1.1. Global Market Revenue Share, By Region, 2025 & 2035

6.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

6.2. Europe

6.2.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

6.2.2. Europe Market Revenue, By Application, 2025-2035

6.2.3. Europe Market Revenue, By Disease, 2025-2035

6.2.4. Germany

6.2.4.1. Germany Market Revenue, By Application, 2025-2035

6.2.4.2. Germany Market Revenue, By Disease, 2025-2035

6.2.5. France

6.2.5.1. France Market Revenue, By Application, 2025-2035

6.2.5.2. France Market Revenue, By Disease, 2025-2035

6.2.6. U.K.

6.2.6.1. U.K. Market Revenue, By Application, 2025-2035

6.2.6.2. U.K. Market Revenue, By Disease, 2025-2035

6.2.7. Italy

6.2.7.1. Italy Market Revenue, By Application, 2025-2035

6.2.7.2. Italy Market Revenue, By Disease, 2025-2035

6.2.8. Spain

6.2.8.1. Spain Market Revenue, By Application, 2025-2035

6.2.8.2. Spain Market Revenue, By Disease, 2025-2035

6.2.9. Switzerland

6.2.9.1. Switzerland Market Revenue, By Application, 2025-2035

6.2.9.2. Switzerland Market Revenue, By Disease, 2025-2035

6.2.10. Netherlands

6.2.10.1. Netherlands Market Revenue, By Application, 2025-2035

6.2.10.2. Netherlands Market Revenue, By Disease, 2025-2035

6.2.11. Belgium

6.2.11.1. Belgium Market Revenue, By Application, 2025-2035

6.2.11.2. Belgium Market Revenue, By Disease, 2025-2035

6.2.12. Sweden

6.2.12.1. Sweden Market Revenue, By Application, 2025-2035

6.2.12.2. Sweden Market Revenue, By Disease, 2025-2035

6.2.13. Poland

6.2.13.1. Poland Market Revenue, By Application, 2025-2035

6.2.13.2. Poland Market Revenue, By Disease, 2025-2035

6.2.14. Portugal

6.2.14.1. Portugal Market Revenue, By Application, 2025-2035

6.2.14.2. Portugal Market Revenue, By Disease, 2025-2035

6.2.15. Greece

6.2.15.1. Greece Market Revenue, By Application, 2025-2035

6.2.15.2. Greece Market Revenue, By Disease, 2025-2035

6.2.16. Czech Republic

6.2.16.1. Czech Republic Market Revenue, By Application, 2025-2035

6.2.16.2. Czech Republic Market Revenue, By Disease, 2025-2035

6.2.17. Hungary

6.2.17.1. Hungary Market Revenue, By Application, 2025-2035

6.2.17.2. Hungary Market Revenue, By Disease, 2025-2035

6.2.18. Finland

6.2.18.1. Finland Market Revenue, By Application, 2025-2035

6.2.18.2. Finland Market Revenue, By Disease, 2025-2035

6.2.19. Rest of Europe

6.2.19.1. Rest of Europe Market Revenue, By Application, 2025-2035

6.2.19.2. Rest of Europe Market Revenue, By Disease, 2025-2035

7. Company Profile

7.1. DeepMind Health

7.1.1. Business Overview

7.1.2. Financial Performance

7.1.3. Product/Service Offerings

7.1.4. Strategies & recent developments

7.1.5. SWOT Analysis

7.2. Qure.ai

7.2.1. Business Overview

7.2.2. Financial Performance

7.2.3. Product/Service Offerings

7.2.4. Strategies & recent developments

7.2.5. SWOT Analysis

7.3. CureMetrix

7.3.1. Business Overview

7.3.2. Financial Performance

7.3.3. Product/Service Offerings

7.3.4. Strategies & recent developments

7.3.5. SWOT Analysis

7.4. Owkin

7.4.1. Business Overview

7.4.2. Financial Performance

7.4.3. Product/Service Offerings

7.4.4. Strategies & recent developments

7.4.5. SWOT Analysis

7.5. PathAI

7.5.1. Business Overview

7.5.2. Financial Performance

7.5.3. Product/Service Offerings

7.5.4. Strategies & recent developments

7.5.5. SWOT Analysis

7.6. Medtronic

7.6.1. Business Overview

7.6.2. Financial Performance

7.6.3. Product/Service Offerings

7.6.4. Strategies & recent developments

7.6.5. SWOT Analysis

7.7. Aidence

7.7.1. Business Overview

7.7.2. Financial Performance

7.7.3. Product/Service Offerings

7.7.4. Strategies & recent developments

7.7.5. SWOT Analysis

7.8. Quantib

7.8.1. Business Overview

7.8.2. Financial Performance

7.8.3. Product/Service Offerings

7.8.4. Strategies & recent developments

7.8.5. SWOT Analysis

7.9. Sophia Genetics

7.9.1. Business Overview

7.9.2. Financial Performance

7.9.3. Product/Service Offerings

7.9.4. Strategies & recent developments

7.9.5. SWOT Analysis

7.10. Mirada Medical

7.10.1. Business Overview

7.10.2. Financial Performance

7.10.3. Product/Service Offerings

7.10.4. Strategies & recent developments

7.10.5. SWOT Analysis

7.11. Siemens Healthineers

7.11.1. Business Overview

7.11.2. Financial Performance

7.11.3. Product/Service Offerings

7.11.4. Strategies & recent developments

7.11.5. SWOT Analysis

7.12. Philips Healthcare

7.12.1. Business Overview

7.12.2. Financial Performance

7.12.3. Product/Service Offerings

7.12.4. Strategies & recent developments

7.12.5. SWOT Analysis

7.13. GE Healthcare

7.13.1. Business Overview

7.13.2. Financial Performance

7.13.3. Product/Service Offerings

7.13.4. Strategies & recent developments

7.13.5. SWOT Analysis

7.14. CureMetrix

7.14.1. Business Overview

7.14.2. Financial Performance

7.14.3. Product/Service Offerings

7.14.4. Strategies & recent developments

7.14.5. SWOT Analysis

7.15. Zebra Medical Vision

7.15.1. Business Overview

7.15.2. Financial Performance

7.15.3. Product/Service Offerings

7.15.4. Strategies & recent developments

7.15.5. SWOT Analysis